Skip to Content
Merck
CN

88450

Thioacetamide

ACS reagent, ≥99.0%

Synonym(s):

Ethanethioamide

Sign In to View Organizational & Contract Pricing.

Select a Size


About This Item

Linear Formula:
CH3CSNH2
CAS Number:
Molecular Weight:
75.13
EC Number:
200-541-4
UNSPSC Code:
23151816
PubChem Substance ID:
Beilstein/REAXYS Number:
506006
MDL number:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

InChI key

YUKQRDCYNOVPGJ-UHFFFAOYSA-N

InChI

1S/C2H5NS/c1-2(3)4/h1H3,(H2,3,4)

SMILES string

CC(N)=S

grade

ACS reagent

assay

≥99.0% (RT), ≥99.0%

form

crystals

ign. residue

≤0.05% (as SO4)

mp

111-114 °C

cation traces

Ca: ≤10 mg/kg, Cd: ≤5 mg/kg, Co: ≤5 mg/kg, Cr: ≤5 mg/kg, Cu: ≤5 mg/kg, Fe: ≤5 mg/kg, K: ≤50 mg/kg, Mg: ≤5 mg/kg, Mn: ≤5 mg/kg, Na: ≤100 mg/kg, Ni: ≤5 mg/kg, Pb: ≤5 mg/kg, Zn: ≤5 mg/kg

Looking for similar products? Visit Product Comparison Guide

Other Notes

Used e.g. for the decomposition of amino acid copper complexes

pictograms

Health hazardExclamation mark

signalword

Danger

Hazard Classifications

Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 1B - Eye Irrit. 2 - Skin Irrit. 2

Storage Class

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Decomposition of amino acid copper complexes using thioacetamide.
U F Taylor et al.
International journal of peptide and protein research, 19(2), 158-161 (1982-02-01)
Chiung-Kuei Huang et al.
Hepatology (Baltimore, Md.), 57(4), 1550-1563 (2012-11-15)
Transplantation of bone marrow mesenchymal stem cells (BM-MSCs) has been considered as an alternative therapy, replacing liver transplantation in clinical trials, to treat liver cirrhosis, an irreversible disease that may eventually lead to liver cancer development. However, low survival rate
Peng Zhan et al.
Archives of pharmacal research, 35(6), 975-986 (2012-08-09)
In continuation of our endeavor to develop new, potent, selective and less toxic antiviral agents, a novel series of 2-(2-amino/chloro-4-(2,4-dibromophenyl) thiazol-5-ylthio)acetamide derivatives was synthesized via an expeditious route and evaluated for their anti-HIV activities against wild-type virus and clinically relevant
Mladen I Yovchev et al.
Hepatology (Baltimore, Md.), 59(1), 284-295 (2013-07-11)
Considerable progress has been made in developing antifibrotic agents and other strategies to treat liver fibrosis; however, significant long-term restoration of functional liver mass has not yet been achieved. Therefore, we investigated whether transplanted hepatic stem/progenitor cells can effectively repopulate
Cun-hua Shao et al.
The Journal of surgical research, 186(1), 408-416 (2013-09-28)
Recent studies have demonstrated that bone marrow-derived mesenchymal stem cells (BM-MSCs) can potentially revert liver fibrosis, but it is not known if preparative hepatic irradiation (HIR) contributes to the therapeutic effect of transplanted BM-MSCs. In this study, we investigate the

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service